Poorly Differentiated Thyroid Gland Carcinoma

Also known as: Poorly differentiated thyroid carcinoma / Insular carcinoma (morphologic abnormality)

Drug	Drug Name	Drug Description

Drug	Drug Name	Target	Type

Drug	Drug Name	Phase	Status	Count
DB00062	Albumin human	2	Active Not Recruiting	1
DB00041	Aldesleukin	2	Active Not Recruiting	1
DB11595	Atezolizumab	2	Active Not Recruiting	1
DB00112	Bevacizumab	2	Active Not Recruiting	1
DB08875	Cabozantinib	2	Active Not Recruiting	1
DB08875	Cabozantinib	2	Completed	1
DB08875	Cabozantinib	2	Terminated	1
DB00515	Cisplatin	2	Unknown Status	1
DB05239	Cobimetinib	2	Active Not Recruiting	1
DB00531	Cyclophosphamide	2	Active Not Recruiting	1
DB08912	Dabrafenib	2	Active Not Recruiting	1
DB01073	Fludarabine	2	Active Not Recruiting	1
DB09293	Iodide I-131	2	Active Not Recruiting	1
DB06186	Ipilimumab	2	Active Not Recruiting	2
DB09078	Lenvatinib	2	Completed	1
DB09078	Lenvatinib	2	Recruiting	1
DB09078	Lenvatinib	2	Terminated	1
DB09078	Lenvatinib	2	Withdrawn	1
DB17107	Lifileucel	2	Active Not Recruiting	1
DB09035	Nivolumab	2	Active Not Recruiting	2
DB01229	Paclitaxel	2	Active Not Recruiting	1
DB09037	Pembrolizumab	2	Completed	1
DB09037	Pembrolizumab	2	Recruiting	1
DB09037	Pembrolizumab	2	Withdrawn	1
DB15685	Selpercatinib	2	Recruiting	1
DB11689	Selumetinib	2	Active Not Recruiting	1
DB00398	Sorafenib	2	Terminated	1
DB14892	Spartalizumab	2	Active Not Recruiting	1
DB08911	Trametinib	2	Active Not Recruiting	2
DB05294	Vandetanib	2	Terminated	1
DB08881	Vemurafenib	2	Active Not Recruiting	1